GLUT-1 as a predictor of worse prognosis in pancreatic adenocarcinoma: immunohistochemistry study showing the correlation between expression and survival

GLUT-1 as a predictor of worse prognosis in pancreatic adenocarcinoma: immunohistochemistry study showing the correlation between expression and survival

Abstract Background Various parameters have been considered for predicting survival in pancreatic ductal adenocarcinoma. Information about western population is missing. The aim of this study is to assess the association between Glucose transporter type 1 (GLUT-1) expression and prognosis for patien...

Full description

Bibliographic Details
Main Authors: Mar Achalandabaso Boira, Marcello Di Martino, Carlos Gordillo, Magdalena Adrados, Elena Martín-Pérez
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Cancer
Subjects:
GLUT-1
Antibody
Pancreatic cancer
Prognostic factor
Online Access:http://link.springer.com/article/10.1186/s12885-020-07409-9

Internet

http://link.springer.com/article/10.1186/s12885-020-07409-9

Similar Items